NEW YORK – Drawing on its longstanding partnership with Becton Dickinson, Babson Diagnostics is aiming to further expand use of its US Food and Drug Administration-cleared blood collection system ...

Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...

Q1 2025 Management View Tom Polen emphasized several key updates, including the planned separation of BD’s Biosciences and Diagnostic Solutions businesses, which aims to create two strategically ...

Becton Dickinson beat expectations for first-quarter results and said its board has authorized a plan to separate its biosciences and diagnostic solutions unit on Wednesday, as the medical device ...

In keeping with the trend in med tech to return to basics, Becton, Dickinson and Co. plans to split off its biosciences and diagnostic solutions unit to create two pure-play companies. The ‘New BD’ or ...

Company working with advisers as it seeks to boost stock price Becton could announce plans with its earnings this week Medical device maker Becton Dickinson & Co. is considering a potential separation ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Becton Dickinson (BDX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

PHILADELPHIA − Mekhi Becton wore a gold necklace with the words "Big Ticket" written in big block letters. And after four long and losing years with the Jets, who made the mammoth 6-foot-7 ...

And only someone as starved for a fresh start as Mekhi Becton could believe it. Drawing on his experience of having Halapoulivaati Vaitai replace injured future Hall of Famer Jason Peters during a ...